Last updated: June 2026 · Reviewed June 2026 · Built by the InjectBuddy team
How do you read a TRT blood panel?
To read a Testosterone (TRT) blood panel, check total and free testosterone against the lab range, then read the safety markers around them — hematocrit, estradiol, SHBG, PSA, and a lipid panel. Timing matters as much as the numbers: with injectable esters, draw blood at the same point in your dosing cycle each time (usually the trough, just before the next injection) so results are comparable.
- Total testosterone tells you the headline level; free testosterone tells you how much is actually active.
- Hematocrit is the main injectable-Testosterone (TRT) safety marker — testosterone raises red-cell mass, and injections carry the highest risk.
- Always draw at the same phase of your cycle (trough for once-weekly esters) or the number means little.
- SHBG drives the gap between total and free; estradiol and PSA round out the panel.
Once you have a total testosterone, SHBG, and albumin result, put them into the free testosterone index calculator to estimate the active fraction.
What is on a Testosterone (TRT) blood panel
A Testosterone (TRT) panel is not one number — it is a small dashboard. The Endocrine Society guideline recommends a standardised monitoring plan that measures serum testosterone and hematocrit during the first year and beyond, alongside symptoms and adverse effects (Bhasin et al., 2018). Most clinics test before starting, then at roughly 1 month, 3–6 months, and annually once stable (StatPearls, Male Hypogonadism).
The markers split into two jobs. Efficacy markers tell you whether the dose is working: total testosterone and free testosterone. Safety markers tell you whether the dose is causing harm: hematocrit (red-cell concentration), estradiol (converted from testosterone), and PSA (prostate). SHBG and albumin are the binding proteins that explain the gap between total and free testosterone — most circulating testosterone is bound to these, and only the unbound fraction acts at the tissue level (StatPearls, Physiology, Testosterone).
Marker-by-marker: what each value means
The table below is a reading guide, not a prescription. Reference ranges differ between labs and assays, so always compare your result to the range printed on your own report rather than a number from a forum.
| Marker | Why it is monitored | Typical adult-male range | Unit |
|---|---|---|---|
| Total testosterone | Headline level — is the dose enough? | ~300–1000 | ng/dL |
| Free testosterone | The unbound, biologically active fraction | ~5–21 (≈1.5–2% of total) | ng/dL |
| SHBG | Binding protein that sets the free fraction | ~18–54 | nmol/L |
| Albumin | Weak-binding protein in free-T formulas | ~3.5–5.0 | g/dL |
| Estradiol (E2) | Aromatized from testosterone; mood/joints | ~10–40 | pg/mL |
| Hematocrit (Hct) | Red-cell concentration — clotting risk | ~41–50 | % |
| PSA | Prostate safety baseline + trend | < 4 (age-dependent) | ng/mL |
Read free testosterone alongside SHBG. A "normal" total testosterone with low SHBG can leave a high free fraction, while the same total with high SHBG can leave a free level that still feels low — which is why the active fraction, not just the headline, is what matters.
Why timing changes the number
Injectable esters do not hold a flat level. After a testosterone enanthate injection, serum levels can climb to several times baseline within 8–24 hours, then decline across the rest of the interval (Nieschlag et al., 1984). So the same weekly dose can read "high" two days post-injection and "low" the morning before the next one. A result without a known draw time is hard to interpret.
The fix is consistency. For a once-weekly ester, the conventional draw is the trough — the morning of injection day, before you inject — because that is the lowest, most reproducible point. For more frequent protocols (every 3.5 days, daily microdosing) the peaks and troughs flatten, so the exact draw time matters less, but you should still standardise it.
Hematocrit: the marker injectors watch most
Testosterone stimulates red-blood-cell production, so the most common abnormal value on an injectable-Testosterone (TRT) panel is a rising hematocrit. A narrative review of Testosterone (TRT)-induced erythrocytosis found injectable formulations carry the highest risk of red-cell elevation, with a recognised link to venous thromboembolism (Jones et al., 2015). StatPearls notes testosterone therapy is generally not recommended when hematocrit already exceeds the upper normal limit (StatPearls, Male Hypogonadism).
Practically, this is why a Testosterone (TRT) panel almost always includes a full blood count. A hematocrit drifting toward 52–54% is the usual trigger for a clinician to discuss reducing the dose, increasing injection frequency (smaller peaks), improving hydration before the draw, or other steps — decisions for your prescriber, not this page.
How this is calculated: total vs free testosterone
Most labs report total testosterone directly from an assay, but free testosterone is often estimated from total testosterone, SHBG, and albumin using a binding equation (the Vermeulen method). The arithmetic below shows the logic without the full quadratic — useful for sanity-checking, not for replacing the lab.
If your report says total testosterone 700 ng/dL and free testosterone 14 ng/dL, the free fraction is 14 / 700 = 0.02, i.e. 2%. That sits in the typical ~1.5–2% band, so the two numbers are internally consistent.
Two men both read total 600 ng/dL. Man A has SHBG 20 nmol/L, Man B has SHBG 55 nmol/L. More binding protein means less unbound hormone, so Man B's free testosterone comes back lower despite the identical total — the headline alone hides it.
To compare a US lab (ng/dL) with a UK lab (nmol/L), multiply ng/dL by 0.0347. So 700 ng/dL × 0.0347 = 24.3 nmol/L. Mixing units without converting is the easiest way to misread a panel.
100 mg enanthate weekly. A trough draw (day 7) reads 450 ng/dL; a peak draw (day 2) on the same dose could read 900+ ng/dL. Same protocol, double the headline — which is why you record the draw day every time.
Baseline Hct 45%. At 3 months it is 49%, at 6 months 52%. No single value is alarming, but a +7-point trend over two draws is the signal a clinician acts on — read the direction, not just the dot.
Estradiol is aromatized from testosterone, so a peak-timed draw that catches a 900 ng/dL testosterone spike will usually show a higher E2 than the same person's trough. Pairing E2 with the testosterone draw time stops a "high E2" false alarm.
A PSA of 1.2 ng/mL before Testosterone (TRT) and 1.4 ng/mL at 12 months is a small, expected drift. The value of the baseline is the comparison — without the pre-treatment number, the follow-up reading has nothing to be read against.
So, how do you read a Testosterone (TRT) blood panel?
To read a Testosterone (TRT) blood panel, check total and free testosterone against the lab’s reference range first, then read the safety markers around them — hematocrit, estradiol, SHBG, PSA and a lipid panel — and always draw blood at the same point in your dosing cycle (usually the trough) so results compare. The numbers only mean something in context, so take them to your prescriber rather than self-adjusting. See how total T, SHBG and albumin combine into free testosterone with the free testosterone calculator.
Frequently asked questions
How do you read a Testosterone (TRT) blood panel?
When should I get blood drawn relative to my injection?
Is total or free testosterone more important?
Why does a Testosterone (TRT) panel include a full blood count?
Are these ranges medical advice?
Sources
- Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018. PubMed PMID: 29562364.
- Nieschlag E, et al. Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate in normal men. Int J Androl. 1984. PubMed PMID: 6434435.
- Jones SD Jr, et al. Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male. Sex Med Rev. 2015. PubMed PMID: 27784544.
- Leslie SW, et al. Male Hypogonadism. StatPearls. NCBI Bookshelf NBK532933.
- Nassar GN, Leslie SW. Physiology, Testosterone. StatPearls. NCBI Bookshelf NBK526128.
This guide is for general educational purposes only and does not constitute medical advice. Reference ranges vary by lab and assay; always read your own report and follow your prescriber's specific instructions.